News and Events - Page 7 of 10 - Precision Biologics

06AugAugust 6, 2019

Dr. Philip M Arlen, will be representing Precision Biologics in the PLENARY KEYNOTE SESSION – Cambridge Healthtech Institute August 8-9, 2019

Dr. Philip M Arlen, will be representing Precision Biologics in the PLENARY KEYNOTE SESSION, PANEL DISCUSSION:...

30AprApril 30, 2019

2019 ASCO Annual Meeting

Abstract Title: Phase 1 with expansion cohorts in a study of NEO-201 in adults with...

12AprApril 12, 2019

Precision Biologics and NCI investigators to discuss NEO-201 development program at First Internation Congress of Bioimmunotherapy of Cancer

First international congress of

BIOIMMUNOTHERAPY OF CANCER

An International multidisciplinary meeting 12-13-14 APRILE 2019 REGGIO CALABRIA ITALY Palazzo della Provincia, Sala...

01AprApril 1, 2019

An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells.

Fantini M, David JM, Wong HC, Annunziata CM, Arlen PM, Tsang KY. Cancer Biother Radiopharm. 2019...

30MarMarch 30, 2019

AACR Annual Meeting

Mechanisms of action of a neoantigen-targeting antibody NEO-201

AACR Annual Meeting - March 30-April 4 2019...

10MarMarch 10, 2019

Dr. Philip M Arlen to deliver to presentations on the NEO-201 program at the Molecular Med Tri-Con Meetings, March 10-15th, SF, CA

The Discovery and Development of Novel Monoclonal Antibody, NEO-201 Targeting a Novel Neoantigen

Philip M. Arlen,...

01NovNovember 1, 2018

The National Cancer Institute Opens Clinical Trial Testing Safety and Dosing of NEO-201 Antibody in Patients with Advanced Cancer

Clinical trial tests safety and dosing of NEO-201 antibody in patients with advanced cancer

NIH 11/01/2018 Patients...

16AprApril 16, 2018

Precision Biologics along with Dr Christina Annunziata, MD, PhD, from the NCI are presenting at the AACR Annual Meeting

The neoantigen-targeting antibody NEO-201 enhances NK cell-dependent killing of tumor cells through blockade...

08JanJanuary 8, 2018

Precision Biologics manuscript on our NEO-201 Antibody article published in Frontiers in Immunology

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

08JanJanuary 8, 2018

Dr. Philip Arlen to Speak at Immunotherapy Progress and Clinical Treatments

Dr. Philip Arlen to Speak at Immunotherapy Progress and Clinical Treatments December 5-7, 2017 in San...